Correspondence on 'Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis' by Rizos et al
- PMID: 35140109
- DOI: 10.1136/heartjnl-2020-318776
Correspondence on 'Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis' by Rizos et al
Keywords: metabolic syndrome; myocardial infarction.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: Correspondence on 'Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis' by Kountouras et al.Heart. 2022 Apr;108(8):657-658. doi: 10.1136/heartjnl-2022-320822. Epub 2022 Feb 9. Heart. 2022. PMID: 35140107 No abstract available.
Comment on
-
Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis.Heart. 2021 Jan;107(2):150-158. doi: 10.1136/heartjnl-2020-316780. Epub 2020 Aug 20. Heart. 2021. PMID: 32820013
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources